Trial intelligence / Profile preview

Stillen vs Cytotec for Prevention of NSAID-Associated Gastroduodenal Injury

NCT01912066Phase 4Completed

Sponsor
Dong-A ST
Start
Sep 2012
Primary completion
Mar 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Stillen, sponsored by Dong-A ST. Started Sep 2012; status: completed.

02

Drugs

Stillen

Beyond the preview

Go deeper on NCT01912066.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01912066.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call